An underground economy for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Investigational Treatment Gaining Popularity Online
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a flourishing market exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and claims of next-day UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Experts Express Worries
However, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could lead to users administering substances of uncertain source.
Some experts stated the popularity for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.
Platform Response and Content Elimination
According to TikTok, the service has taken down violative content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the service safe and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Research also found groups with up to 9,000 members marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, populated with images of slimming results, glowing testimonials and detailed guides for preparing or administering at residence.
Within minutes of entering one group, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, health issues or previous experience.
Product Details and Costs
Inside these groups, posts display black plastic parcels with Royal Mail stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram said it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they can’t verify. Although the science behind retatrutide is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may subject patients to potentially serious medical dangers”.
